<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hyperbaric oxygen (HBO) and normobaric <z:mp ids='MP_0002319'>hyperoxia</z:mp> (NBO) protect the brain parenchyma and the cerebral microcirculation against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We studied their effect on secondary <z:mp ids='MP_0001914'>hemorrhage</z:mp> after thrombolysis in two thromboembolic middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) (tMCAO) models </plain></SENT>
<SENT sid="2" pm="."><plain>Beginning 60 minutes after tMCAO with either thrombin-induced thromboemboli (TT) or calcium-induced thromboemboli (CT), spontaneously hypertensive rats (n=96) breathed either air, 100% <z:chebi fb="0" ids="15379">O(2)</z:chebi> (NBO), or 100% <z:chebi fb="0" ids="15379">O(2)</z:chebi> at 3 bar (HBO) for 1 hour </plain></SENT>
<SENT sid="3" pm="."><plain>Immediately thereafter, recombinant tissue plasminogen activator (rt-PA, 9 mg/kg) was injected </plain></SENT>
<SENT sid="4" pm="."><plain>Although significant reperfusion was observed after thrombolysis in TT-tMCAO, <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> persisted in CT-tMCAO </plain></SENT>
<SENT sid="5" pm="."><plain>In TT-tMCAO, NBO and HBO significantly reduced diffusion-weighted imaging-magnetic resonance imaging (MRI) lesion volume and postischemic blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) permeability on postcontrast T1-weighted images </plain></SENT>
<SENT sid="6" pm="."><plain>NBO and, significantly more potently, HBO reduced macroscopic <z:mp ids='MP_0001914'>hemorrhage</z:mp> on T2* MRI and on corresponding postmortem cryosections </plain></SENT>
<SENT sid="7" pm="."><plain>Oxygen therapy lowered <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> content and attenuated activation of matrix metalloproteinases in the ischemic hemisphere </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, NBO and HBO failed to reduce <z:mpath ids='MPATH_124'>infarct</z:mpath> size in CT but both decreased <z:chebi fb="2" ids="33602">BBB</z:chebi> damage and microscopic hemorrhagic transformation </plain></SENT>
<SENT sid="9" pm="."><plain>Only HBO reduced <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> extravasation in the ischemic hemisphere </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, NBO and HBO decrease <z:mpath ids='MPATH_124'>infarct</z:mpath> size after thromboembolic <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> only if recanalization is successful </plain></SENT>
<SENT sid="11" pm="."><plain>As NBO and HBO also reduce postthrombolytic <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo>, combining the two with thrombolysis seems promising </plain></SENT>
</text></document>